CAR T CELL THERAPY MARKET (BY TARGETED ANTIGEN – HER1, HER2, CD19, CD20, CD22, CD30, CD33, GD2, MESO AND EGFRVIII, BY TREATMENT - NON-HODGKIN LYMPHOMA (NHL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), MULTIPLE MYELOMA, ACUTE MYELOID LEUKEMIA (AML), BREAST CANCER, PANCREATIC CANCER, NEUROBLASTOMA (NB), COLON CANCER AND HEPATOCELLULAR CARCINOMA (HCC)) – GLOBAL INDUSTRY ANALYSIS, SIZE, SHARE, GROWTH, TRENDS AND FORECAST, 2017 – 2025


Report Type : Syndicate Report

Published : December, 2017 | Pages : 155 | Format : Word PDF, PPT PDF, Excel | Report Id : HC120-2